A nanotechnology-based drug delivery system developed at UVA Health to save patients from repeated surgeries has proved to have unexpectedly long-lasting benefits in lab tests—a promising sign for its ...
Greater inclusion of women in surgical trials and reporting of sex-based treatment effects are warranted, they say.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback